RESOURCES | PRESENTATIONS, PUBLICATIONS, AND POSTERS | Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples
     

    Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples

    Nov 13, 2019

    Vijayendra Agrawal Ph.D. , Mibel Pabon, Ph.D. , Tina Pastoor, M.S , Jenny Kreahling, Ph.D. and Soner Altiok, M.D., Ph.D.

    DOWNLOAD poster

    OTHER PUBLICATIONS

    Employing ex vivo 3D-Screen technology for the development of rational combinations of immuno-oncology drugs in tumor organoids of fresh patient tissue

    Employing ex vivo 3D-Screen technology for the development of rational combinations of immuno-oncology drugs in tumor organoids of fresh patient tissue

    Jared Ehrhart, Ph.D., Mibel Pabón, Ph.D., Tina Pastoor...

    Jun 22, 2020

    Optimization of checkpoint inhibitor-TKI combinations in renal cell carcinoma using an ex vivo 3D tumor organoid model of fresh patient tissue with intact TME

    Optimization of checkpoint inhibitor-TKI combinations in renal cell carcinoma using an ex vivo 3D tumor organoid model of fresh patient tissue with intact TME

    Jared C. Ehrhart, Ph.D., Mibel Pabón, Ph.D., Tina Past...

    Jun 22, 2020

    Impact of Combined Blockade of PD1 and Activation of CD137 on Tumor Infiltration and Tumor Cell Killing Efficacy of Tumor Infiltrating Lymphocytes (TILs) in an Ex Vivo Autologous 3D Tumoroid Model of NSCLC Patient Samples.

    Impact of Combined Blockade of PD1 and Activation of CD137 on Tumor Infiltration and Tumor Cell Killing Efficacy of Tumor Infiltrating Lymphocytes (TILs) in an Ex Vivo Autologous 3D Tumoroid Model of NSCLC Patient Samples.

    Melba Marie Page, Ph.D., Vijayendra Agrawal Ph.D., Mibe...

    Nov 13, 2019

    SHOW MORE